A detailed history of Jackson Square Partners, LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Jackson Square Partners, LLC holds 6,296,116 shares of PACB stock, worth $12.5 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares
6,296,116
Previous 8,883,443 29.13%
Holding current value
$12.5 Million
Previous $12.2 Million 12.05%
% of portfolio
0.93%
Previous 0.75%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$1.2 - $2.17 $3.1 Million - $5.61 Million
-2,587,327 Reduced 29.13%
6,296,116 $10.7 Million
Q2 2024

Aug 13, 2024

BUY
$1.36 - $3.65 $2.31 Million - $6.2 Million
1,699,130 Added 23.65%
8,883,443 $12.2 Million
Q1 2024

May 08, 2024

SELL
$3.52 - $9.59 $8.87 Million - $24.2 Million
-2,520,453 Reduced 25.97%
7,184,313 $26.9 Million
Q4 2023

Feb 08, 2024

BUY
$5.97 - $10.36 $16.5 Million - $28.7 Million
2,770,901 Added 39.96%
9,704,766 $95.2 Million
Q3 2023

Nov 13, 2023

SELL
$8.23 - $13.93 $13 Million - $22.1 Million
-1,583,759 Reduced 18.59%
6,933,865 $57.9 Million
Q2 2023

Aug 11, 2023

SELL
$9.97 - $14.05 $35.7 Million - $50.3 Million
-3,580,337 Reduced 29.59%
8,517,624 $113 Million
Q1 2023

May 11, 2023

SELL
$7.94 - $12.02 $23.1 Million - $34.9 Million
-2,907,216 Reduced 19.37%
12,097,961 $140 Million
Q4 2022

Feb 09, 2023

SELL
$5.67 - $11.2 $29.8 Million - $58.8 Million
-5,252,922 Reduced 25.93%
15,005,177 $123 Million
Q3 2022

Nov 14, 2022

SELL
$3.93 - $8.57 $9.84 Million - $21.5 Million
-2,503,943 Reduced 11.0%
20,258,099 $118 Million
Q2 2022

Aug 12, 2022

BUY
$4.02 - $10.43 $882,201 - $2.29 Million
219,453 Added 0.97%
22,762,042 $101 Million
Q1 2022

May 13, 2022

BUY
$8.43 - $20.9 $67.8 Million - $168 Million
8,039,420 Added 55.43%
22,542,589 $205 Million
Q4 2021

Feb 14, 2022

SELL
$19.26 - $30.08 $645,248 - $1.01 Million
-33,502 Reduced 0.23%
14,503,169 $297 Million
Q3 2021

Nov 12, 2021

SELL
$24.86 - $35.02 $7.45 Million - $10.5 Million
-299,823 Reduced 2.02%
14,536,671 $371 Million
Q2 2021

Aug 13, 2021

BUY
$22.3 - $36.02 $42.9 Million - $69.3 Million
1,924,799 Added 14.91%
14,836,494 $519 Million
Q1 2021

May 13, 2021

SELL
$26.38 - $51.15 $14.8 Million - $28.8 Million
-562,743 Reduced 4.18%
12,911,695 $430 Million
Q4 2020

Feb 12, 2021

BUY
$10.5 - $28.5 $141 Million - $384 Million
13,474,438 New
13,474,438 $350 Million

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $447M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Jackson Square Partners, LLC Portfolio

Follow Jackson Square Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Square Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Square Partners, LLC with notifications on news.